The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Andrographolide Drug Market Research Report 2025
Synopsis
The global Andrographolide Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Significant curative effect: Andrographolide has the effects of clearing heat, detoxifying, antibacterial and anti-inflammatory, and has a good therapeutic effect on upper respiratory tract infections, gastrointestinal infections, urinary system infections and other infectious diseases. Its efficacy is remarkable and has been widely recognized by doctors and patients.
Market demand: With the improvement of people's living standards and the enhancement of health awareness, the demand for the prevention and treatment of common diseases continues to increase. Andrographolide drug is one of the commonly used antibacterial and anti-inflammatory drugs, and its market demand continues to grow.
This report aims to provide a comprehensive presentation of the global market for Andrographolide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Andrographolide Drug.
Report Scope
The Andrographolide Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Andrographolide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Andrographolide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tasly Group
Furen Pharmaceutical
Jiuhui Pharmaceutical
Sunflower Pharmaceutical
Nanjing Zhengke Pharmaceutical
Livzon Pharm
HORMOSAN Pharma
Segment by Type
Capsule
Pill
Tablet
Segment by Application
Hospital Clinic
Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Andrographolide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Andrographolide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Andrographolide Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Significant curative effect: Andrographolide has the effects of clearing heat, detoxifying, antibacterial and anti-inflammatory, and has a good therapeutic effect on upper respiratory tract infections, gastrointestinal infections, urinary system infections and other infectious diseases. Its efficacy is remarkable and has been widely recognized by doctors and patients.
Market demand: With the improvement of people's living standards and the enhancement of health awareness, the demand for the prevention and treatment of common diseases continues to increase. Andrographolide drug is one of the commonly used antibacterial and anti-inflammatory drugs, and its market demand continues to grow.
This report aims to provide a comprehensive presentation of the global market for Andrographolide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Andrographolide Drug.
Report Scope
The Andrographolide Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Andrographolide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Andrographolide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tasly Group
Furen Pharmaceutical
Jiuhui Pharmaceutical
Sunflower Pharmaceutical
Nanjing Zhengke Pharmaceutical
Livzon Pharm
HORMOSAN Pharma
Segment by Type
Capsule
Pill
Tablet
Segment by Application
Hospital Clinic
Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Andrographolide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Andrographolide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Andrographolide Drug Market Overview
1.1 Product Overview and Scope of Andrographolide Drug
1.2 Andrographolide Drug Segment by Type
1.2.1 Global Andrographolide Drug Market Value Comparison by Type (2024-2030)
1.2.2 Capsule
1.2.3 Pill
1.2.4 Tablet
1.3 Andrographolide Drug Segment by Application
1.3.1 Global Andrographolide Drug Market Value by Application: (2024-2030)
1.3.2 Hospital Clinic
1.3.3 Pharmacy
1.3.4 Online Pharmacy
1.4 Global Andrographolide Drug Market Size Estimates and Forecasts
1.4.1 Global Andrographolide Drug Revenue 2019-2030
1.4.2 Global Andrographolide Drug Sales 2019-2030
1.4.3 Global Andrographolide Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Andrographolide Drug Market Competition by Manufacturers
2.1 Global Andrographolide Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Andrographolide Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Andrographolide Drug Average Price by Manufacturers (2019-2024)
2.4 Global Andrographolide Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Andrographolide Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Andrographolide Drug, Product Type & Application
2.7 Andrographolide Drug Market Competitive Situation and Trends
2.7.1 Andrographolide Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Andrographolide Drug Players Market Share by Revenue
2.7.3 Global Andrographolide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Andrographolide Drug Retrospective Market Scenario by Region
3.1 Global Andrographolide Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Andrographolide Drug Global Andrographolide Drug Sales by Region: 2019-2030
3.2.1 Global Andrographolide Drug Sales by Region: 2019-2024
3.2.2 Global Andrographolide Drug Sales by Region: 2025-2030
3.3 Global Andrographolide Drug Global Andrographolide Drug Revenue by Region: 2019-2030
3.3.1 Global Andrographolide Drug Revenue by Region: 2019-2024
3.3.2 Global Andrographolide Drug Revenue by Region: 2025-2030
3.4 North America Andrographolide Drug Market Facts & Figures by Country
3.4.1 North America Andrographolide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Andrographolide Drug Sales by Country (2019-2030)
3.4.3 North America Andrographolide Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographolide Drug Market Facts & Figures by Country
3.5.1 Europe Andrographolide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Andrographolide Drug Sales by Country (2019-2030)
3.5.3 Europe Andrographolide Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographolide Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Andrographolide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Andrographolide Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Andrographolide Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Andrographolide Drug Market Facts & Figures by Country
3.7.1 Latin America Andrographolide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Andrographolide Drug Sales by Country (2019-2030)
3.7.3 Latin America Andrographolide Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Andrographolide Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographolide Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Andrographolide Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Andrographolide Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographolide Drug Sales by Type (2019-2030)
4.1.1 Global Andrographolide Drug Sales by Type (2019-2024)
4.1.2 Global Andrographolide Drug Sales by Type (2025-2030)
4.1.3 Global Andrographolide Drug Sales Market Share by Type (2019-2030)
4.2 Global Andrographolide Drug Revenue by Type (2019-2030)
4.2.1 Global Andrographolide Drug Revenue by Type (2019-2024)
4.2.2 Global Andrographolide Drug Revenue by Type (2025-2030)
4.2.3 Global Andrographolide Drug Revenue Market Share by Type (2019-2030)
4.3 Global Andrographolide Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Andrographolide Drug Sales by Application (2019-2030)
5.1.1 Global Andrographolide Drug Sales by Application (2019-2024)
5.1.2 Global Andrographolide Drug Sales by Application (2025-2030)
5.1.3 Global Andrographolide Drug Sales Market Share by Application (2019-2030)
5.2 Global Andrographolide Drug Revenue by Application (2019-2030)
5.2.1 Global Andrographolide Drug Revenue by Application (2019-2024)
5.2.2 Global Andrographolide Drug Revenue by Application (2025-2030)
5.2.3 Global Andrographolide Drug Revenue Market Share by Application (2019-2030)
5.3 Global Andrographolide Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Tasly Group
6.1.1 Tasly Group Corporation Information
6.1.2 Tasly Group Description and Business Overview
6.1.3 Tasly Group Andrographolide Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Tasly Group Andrographolide Drug Product Portfolio
6.1.5 Tasly Group Recent Developments/Updates
6.2 Furen Pharmaceutical
6.2.1 Furen Pharmaceutical Corporation Information
6.2.2 Furen Pharmaceutical Description and Business Overview
6.2.3 Furen Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Furen Pharmaceutical Andrographolide Drug Product Portfolio
6.2.5 Furen Pharmaceutical Recent Developments/Updates
6.3 Jiuhui Pharmaceutical
6.3.1 Jiuhui Pharmaceutical Corporation Information
6.3.2 Jiuhui Pharmaceutical Description and Business Overview
6.3.3 Jiuhui Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jiuhui Pharmaceutical Andrographolide Drug Product Portfolio
6.3.5 Jiuhui Pharmaceutical Recent Developments/Updates
6.4 Sunflower Pharmaceutical
6.4.1 Sunflower Pharmaceutical Corporation Information
6.4.2 Sunflower Pharmaceutical Description and Business Overview
6.4.3 Sunflower Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sunflower Pharmaceutical Andrographolide Drug Product Portfolio
6.4.5 Sunflower Pharmaceutical Recent Developments/Updates
6.5 Nanjing Zhengke Pharmaceutical
6.5.1 Nanjing Zhengke Pharmaceutical Corporation Information
6.5.2 Nanjing Zhengke Pharmaceutical Description and Business Overview
6.5.3 Nanjing Zhengke Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nanjing Zhengke Pharmaceutical Andrographolide Drug Product Portfolio
6.5.5 Nanjing Zhengke Pharmaceutical Recent Developments/Updates
6.6 Livzon Pharm
6.6.1 Livzon Pharm Corporation Information
6.6.2 Livzon Pharm Description and Business Overview
6.6.3 Livzon Pharm Andrographolide Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Livzon Pharm Andrographolide Drug Product Portfolio
6.6.5 Livzon Pharm Recent Developments/Updates
6.7 HORMOSAN Pharma
6.6.1 HORMOSAN Pharma Corporation Information
6.6.2 HORMOSAN Pharma Description and Business Overview
6.6.3 HORMOSAN Pharma Andrographolide Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HORMOSAN Pharma Andrographolide Drug Product Portfolio
6.7.5 HORMOSAN Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographolide Drug Industry Chain Analysis
7.2 Andrographolide Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographolide Drug Production Mode & Process
7.4 Andrographolide Drug Sales and Marketing
7.4.1 Andrographolide Drug Sales Channels
7.4.2 Andrographolide Drug Distributors
7.5 Andrographolide Drug Customers
8 Andrographolide Drug Market Dynamics
8.1 Andrographolide Drug Industry Trends
8.2 Andrographolide Drug Market Drivers
8.3 Andrographolide Drug Market Challenges
8.4 Andrographolide Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
